We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+11.8%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$804M
AUM Growth
-$172M
(-18%)
Cap. Flow
-$244M
Cap. Flow
% of AUM
-30.33%
Top 10 Holdings %
Top 10 Hldgs %
59.25%
Holding
273
New
116
Increased
49
Reduced
44
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$9.36M |
| 2 |
Assurant
AIZ
|
+$8.7M |
| 3 |
Allstate
ALL
|
+$7.12M |
| 4 |
Old Republic International
ORI
|
+$6.43M |
| 5 |
Thomson Reuters
TRI
|
+$5.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$349M |
| 2 |
Northern Trust
NTRS
|
+$10.2M |
| 3 |
T. Rowe Price
TROW
|
+$8.12M |
| 4 |
Raymond James Financial
RJF
|
+$7.49M |
| 5 |
Ameriprise Financial
AMP
|
+$6.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.57% |
| 2 | Financials | 16.5% |
| 3 | Industrials | 6.66% |
| 4 | Real Estate | 6.32% |
| 5 | Technology | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Carlisle Companies
CSL
$14.3B
| $1.58M | 0.2% |
15,167
+953
| +7% | +$104K |
|
102
Iovance Biotherapeutics
IOVA
$1.82B
| $1.58M | 0.2% |
+93,346
| New | +$1.41M |
|
103
Verizon
VZ
$195B
| $1.58M | 0.2% |
+33,000
| New | +$1.66M |
|
104
Paychex
PAYX
$41.6B
| $1.55M | 0.19% |
25,200
+4,200
| +20% | +$278K |
|
|
SEE
105
DELISTED
Sealed Air
SEE
| $1.53M | 0.19% |
+35,849
| New | +$1.62M |
|
106
Minerals Technologies
MTX
$2.36B
| $1.52M | 0.19% |
22,686
-2,892
| -11% | -$207K |
|
107
Ardelyx
ARDX
$1.22B
| $1.51M | 0.19% |
299,750
-161,412
| -35% | -$1.01M |
|
108
Exponent
EXPO
$3.24B
| $1.47M | 0.18% |
37,354
-18,326
| -33% | -$693K |
|
109
Hartford Financial Services
HIG
$38.9B
| $1.42M | 0.18% |
27,621
-93,790
| -77% | -$5.13M |
|
|
TREC
110
DELISTED
Trecora Resources
TREC
| $1.41M | 0.18% |
103,552
| – | – |
|
|
TLND
111
DELISTED
Talend S.A. American Depositary Shares
TLND
| $1.38M | 0.17% |
+28,680
| New | +$1.22M |
|
112
Globe Life
GL
$14.2B
| $1.38M | 0.17% |
+16,387
| New | +$1.43M |
|
113
NNN REIT
NNN
$9.04B
| $1.38M | 0.17% |
+35,067
| New | +$1.37M |
|
|
BDN
114
Brandywine Realty Trust
BDN
$524M
| $1.37M | 0.17% |
+86,539
| New | +$1.44M |
|
115
Kemper
KMPR
$1.67B
| $1.37M | 0.17% |
+24,076
| New | +$1.48M |
|
|
GCP
116
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.36M | 0.17% |
46,850
+16,997
| +57% | +$548K |
|
|
INFO
117
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $1.35M | 0.17% |
+28,067
| New | +$1.33M |
|
118
Microchip Technology
MCHP
$40.3B
| $1.32M | 0.16% |
29,000
-36,600
| -56% | -$1.69M |
|
119
Urban Edge Properties
UE
$2.86B
| $1.3M | 0.16% |
+60,916
| New | +$1.37M |
|
120
Analog Devices
ADI
$179B
| $1.28M | 0.16% |
14,000
-7,000
| -33% | -$637K |
|
|
DSKE
121
DELISTED
Daseke, Inc. Common Stock
DSKE
| $1.27M | 0.16% |
129,954
+80,889
| +165% | +$966K |
|
|
OTIC
122
DELISTED
Otonomy, Inc.
OTIC
| $1.25M | 0.16% |
297,559
+32,911
| +12% | +$179K |
|
|
GWPH
123
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.24M | 0.15% |
+10,961
| New | +$1.38M |
|
|
CHL
124
DELISTED
China Mobile Limited
CHL
| $1.24M | 0.15% |
27,000
-46,400
| -63% | -$2.25M |
|
125
Synopsys
SNPS
$74.4B
| $1.23M | 0.15% |
+14,750
| New | +$1.3M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2018 Portfolio in Review
As of Q1 2018, Crestline Management held 273 positions worth $804M, down 18% from $976M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Crestline Management withdrew a net $244M in Q1 2018, closing 63 positions and reducing 44 holdings. Its most notable exit was Juno Therapeutics, Inc., an estimated $349M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 38% a quarter earlier, followed by Financials and Industrials.
Against the trend, Crestline Management opened a new position in Principal Financial Group worth $8.66M.
- Crestline Management's largest Q1 2018 buy was Principal Financial Group: 142,238 shares worth $8.66M.
- Crestline Management added most to Old Republic International in Q1 2018, an estimated $6.43M increase.
- Crestline Management's biggest Q1 2018 reduction was Ameriprise Financial, cutting an estimated $6.18M.
- Crestline Management fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $349M.
- Crestline Management's ten largest holdings make up 59% of its $804M portfolio in Q1 2018.
- Crestline Management opened 116 new positions and closed 63 in Q1 2018.
- Crestline Management's portfolio value fell 18% quarter-over-quarter to $804M.
Based on Crestline Management's 13F filing for Q1 2018, filed 15 May 2018.